Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
RemeGen Co. Ltd. Class H ( (HK:9995) ) has provided an announcement.
RemeGen Co., Ltd. has established a Nomination Committee under its Board to enhance corporate governance by regulating the selection and appointment of directors. The committee is tasked with ensuring that board members possess the necessary skills, experience, and diversity to align with the company’s strategic objectives and values, while also making recommendations on appointments and succession planning for senior management.
The most recent analyst rating on (HK:9995) stock is a Buy with a HK$19.59 price target. To see the full list of analyst forecasts on RemeGen Co. Ltd. Class H stock, see the HK:9995 Stock Forecast page.
More about RemeGen Co. Ltd. Class H
RemeGen Co., Ltd. operates in the biotechnology industry, focusing on the development and commercialization of innovative medicines. The company is committed to enhancing its corporate governance structure and optimizing board composition.
Average Trading Volume: 9,367,111
Technical Sentiment Signal: Buy
Current Market Cap: HK$31.81B
For an in-depth examination of 9995 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue